Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome
QMRO Home
William Harvey Research Institute
Centre for Microvascular Research (CMR)
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome
QMRO Home
William Harvey Research Institute
Centre for Microvascular Research (CMR)
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome
View/
Open
Published version (5.558Mb)
Volume
7
Pagination
1300 - 1310
DOI
10.1021/acscentsci.0c01698
Journal
ACS CENTRAL SCIENCE
Issue
8
ISSN
2374-7943
Metadata
Show full item record
Authors
Marcos-Ramiro, B; Gil-Ordonez, A; Marin-Ramos, NI; Ortega-Nogales, FJ; Balabasquer, M; Gonzalo, P; Khiar-Fernandez, N; Rolas, L; Barkaway, A; Nourshargh, S
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/97682
Collections
Centre for Microvascular Research (CMR)
[104]
Licence information
This publication is licensed under CC-BY-NC-ND 4.0.
Copyright statements
© 2021 The Authors. Published by American Chemical Society